EarningsQ2 2023 Earnings Report

Rhythm Pharmaceuticals (RYTM) Q2 2023 Earnings Report

1 Followers

MX:RYTM Q2 2023 EPS Results

Actual EPS-$14.89

Consensus EPS-$14.49

Beat/MissMissed by -$0.40

One Year Ago EPS-$16.16

Actual Revenue$349.07M

Expected Revenue$272.94M

Beat/MissBeat by +$76.13M

YoY Revenue Growth+112.01%

QuarterQ2 2023

Date08/01/2023

TimeBefore Open

Conference CallTuesday, August 1, 2023

MX:RYTM Upcoming Earnings

Rhythm Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

MX:RYTM Q2 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-13.13 / -	-14.892	―
Aug 04, 2026	2026 (Q2)	-14.66 / -13.26	-13.621	2.67% (+0.36)
May 05, 2026	2026 (Q1)	-14.93 / -15.07	-14.71	-2.47% (-0.36)
Feb 26, 2026	2025 (Q4)	-14.62 / -13.26	-13.076	-1.39% (-0.18)
Nov 04, 2025	2025 (Q3)	-12.86 / -14.89	-13.257	-12.33% (-1.63)
Aug 05, 2025	2025 (Q2)	-12.17 / -13.62	-9.988	-36.36% (-3.63)
May 07, 2025	2025 (Q1)	-12.60 / -14.71	-42.678	65.53% (+27.97)
Feb 26, 2025	2024 (Q4)	-12.60 / -13.08	-12.712	-2.86% (-0.36)
Nov 05, 2024	2024 (Q3)	-14.62 / -13.26	-13.802	3.95% (+0.54)
Aug 06, 2024	2024 (Q2)	-12.88 / -9.99	-14.892	32.93% (+4.90)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed